Great West Life Assurance CO Aclaris Therapeutics, Inc. Transaction History

Great West Life Assurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$13.07 - $18.22 $25,408 - $35,419	1,944 New	1,944 $31,000
Q2 2021 Aug 11, 2021	BUY	$17.08 - $29.6 $33,203 - $57,542	1,944 New	1,944 $34,000
Q2 2019 Jul 31, 2019	SELL	$2.13 - $7.06 $12,933 - $42,868	-6,072 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$6.3 - $15.4 $38,253 - $93,508	6,072 New	6,072 $43,000
Q1 2018 May 10, 2018	SELL	$17.08 - $25.64 $89,533 - $134,404	-5,242 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$21.47 - $27.8 $86,781 - $112,367	4,042 Added 336.83%	5,242 $129,000
Q3 2017 Nov 09, 2017	BUY	$23.02 - $28.8 $27,624 - $34,560	1,200	1,200 $31,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.